Table 2.
Sites of initial failure
| All patients (n = 52) |
Patients with OF (n = 26) |
Patients with DF (n = 12) |
Patient with ODF (n = 14) |
|
|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | |
| Initial PD | ||||
| Primary only | 9 (17.3) | 7 (26.9) | 0 (0.0) | 0 (0.0) |
| Metastasis only | 33 (63.5) | 16 (61.5) | 12 (100.0) | 7 (50.0) |
| Primary and metastasis | 10 (19.2) | 3 (11.5) | 0 (0.0) | 7 (50.0) |
| Site of initial failure | ||||
| Lung | 17 (32.7) | 7 (26.9) | 2 (16.7) | 8 (57.1) |
| Liver | 3 (5.8) | 2 (7.7) | 0 | 1 (7.1) |
| Brain | 31 (59.6) | 15 (57.7) | 6 (50.0) | 10 (71.4) |
| Bone | 6 (11.5) | 1 (3.8) | 3 (25.0) | 2 (14.3) |
| Adrenal grand | 1 (1.9) | 0 (0.0) | 0 | 1 (7.1) |
| Regional LN | 6 (11.5) | 3 (11.5) | 0 | 3 (21.4) |
| Distant LN | 4 (7.7) | 2 (7.7) | 0 | 2 (14.3) |
| others | 3 (5.8) | 1 (3.8) | 1 (8.3) | 1 (7.1) |
OF original site failure, DF distant site failure, ODF simultaneous occurrence of OF and DF, n number, PD disease progression, LN lymph node